ATE311388T1 - Pyrimidotriazine als phosphataseinhibitoren - Google Patents
Pyrimidotriazine als phosphataseinhibitorenInfo
- Publication number
- ATE311388T1 ATE311388T1 AT02805774T AT02805774T ATE311388T1 AT E311388 T1 ATE311388 T1 AT E311388T1 AT 02805774 T AT02805774 T AT 02805774T AT 02805774 T AT02805774 T AT 02805774T AT E311388 T1 ATE311388 T1 AT E311388T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidotriazines
- phosphatase inhibitors
- pyrimido
- triazine
- useful
- Prior art date
Links
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 title 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 abstract 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 abstract 1
- 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 abstract 1
- ACMYQAYEINJXQI-UHFFFAOYSA-N pyrimido[5,4-e][1,2,4]triazine-5,7-diamine Chemical class N1=CN=NC2=NC(N)=NC(N)=C21 ACMYQAYEINJXQI-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34393701P | 2001-12-27 | 2001-12-27 | |
| US39911002P | 2002-07-26 | 2002-07-26 | |
| PCT/EP2002/014771 WO2003055883A1 (en) | 2001-12-27 | 2002-12-27 | Pyrimidotriazines as phosphatase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE311388T1 true ATE311388T1 (de) | 2005-12-15 |
Family
ID=26993696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02805774T ATE311388T1 (de) | 2001-12-27 | 2002-12-27 | Pyrimidotriazine als phosphataseinhibitoren |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6642381B2 (https=) |
| EP (1) | EP1467996B1 (https=) |
| JP (1) | JP4188839B2 (https=) |
| KR (1) | KR100601769B1 (https=) |
| CN (1) | CN100402530C (https=) |
| AT (1) | ATE311388T1 (https=) |
| AU (1) | AU2002367190B2 (https=) |
| BR (1) | BR0215395A (https=) |
| CA (1) | CA2471265C (https=) |
| DE (1) | DE60207759T2 (https=) |
| ES (1) | ES2252554T3 (https=) |
| JO (1) | JO2242B1 (https=) |
| MX (1) | MXPA04006266A (https=) |
| PA (1) | PA8562901A1 (https=) |
| PE (1) | PE20030896A1 (https=) |
| PL (1) | PL371180A1 (https=) |
| TW (1) | TW200306313A (https=) |
| UY (1) | UY27606A1 (https=) |
| WO (1) | WO2003055883A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696231B2 (en) * | 2001-10-30 | 2010-04-13 | Laboratoires Serono Sa | Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) |
| BR0316375A (pt) | 2002-11-18 | 2005-10-04 | Hoffmann La Roche | Diazinopirimidinas |
| JP2006518738A (ja) * | 2003-02-12 | 2006-08-17 | トランス テック ファーマ，インコーポレイテッド | 治療薬としての置換アゾール誘導体 |
| WO2004071448A2 (en) * | 2003-02-12 | 2004-08-26 | Transtech Pharma Inc. | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| JP4898458B2 (ja) * | 2004-02-12 | 2012-03-14 | トランス テック ファーマ，インコーポレイテッド | 置換アゾール誘導体、組成物及び使用方法 |
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| BRPI0707338A2 (pt) | 2006-01-30 | 2011-05-03 | Transtech Pharma Inc | derivados de imidazol, composições, e métodos substituìdos de uso como inibidores de ptpase |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| WO2010083645A1 (en) * | 2009-01-21 | 2010-07-29 | Shanghai Targetdrug Co., Ltd | PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2014057522A1 (en) | 2012-10-12 | 2014-04-17 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| SG11201507288UA (en) | 2013-03-15 | 2015-10-29 | Mochida Pharm Co Ltd | Compositions and methods for treating non-alcoholic steatohepatitis |
| US10441560B2 (en) | 2013-03-15 | 2019-10-15 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| SI3004138T1 (sl) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Limited | Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194410B1 (en) * | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
| PA8474101A1 (es) | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| GB0022079D0 (en) | 2000-09-08 | 2000-10-25 | Inst Of Molecul & Cell Biology | Novel protein tyrosine phosphatase inhibitor |
-
2002
- 2002-12-10 US US10/315,769 patent/US6642381B2/en not_active Expired - Fee Related
- 2002-12-24 PA PA20028562901A patent/PA8562901A1/es unknown
- 2002-12-25 TW TW091137302A patent/TW200306313A/zh unknown
- 2002-12-26 UY UY27606A patent/UY27606A1/es not_active Application Discontinuation
- 2002-12-26 JO JO2002137A patent/JO2242B1/en active
- 2002-12-27 DE DE60207759T patent/DE60207759T2/de not_active Expired - Lifetime
- 2002-12-27 JP JP2003556413A patent/JP4188839B2/ja not_active Expired - Fee Related
- 2002-12-27 CN CNB028264223A patent/CN100402530C/zh not_active Expired - Fee Related
- 2002-12-27 KR KR1020047010017A patent/KR100601769B1/ko not_active Expired - Fee Related
- 2002-12-27 PL PL02371180A patent/PL371180A1/xx not_active Application Discontinuation
- 2002-12-27 BR BR0215395-5A patent/BR0215395A/pt not_active IP Right Cessation
- 2002-12-27 AU AU2002367190A patent/AU2002367190B2/en not_active Ceased
- 2002-12-27 WO PCT/EP2002/014771 patent/WO2003055883A1/en not_active Ceased
- 2002-12-27 MX MXPA04006266A patent/MXPA04006266A/es active IP Right Grant
- 2002-12-27 EP EP02805774A patent/EP1467996B1/en not_active Expired - Lifetime
- 2002-12-27 ES ES02805774T patent/ES2252554T3/es not_active Expired - Lifetime
- 2002-12-27 CA CA2471265A patent/CA2471265C/en not_active Expired - Fee Related
- 2002-12-27 AT AT02805774T patent/ATE311388T1/de not_active IP Right Cessation
-
2003
- 2003-01-06 PE PE2003000022A patent/PE20030896A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1467996B1 (en) | 2005-11-30 |
| DE60207759D1 (de) | 2006-01-05 |
| PA8562901A1 (es) | 2003-07-28 |
| US6642381B2 (en) | 2003-11-04 |
| MXPA04006266A (es) | 2004-09-27 |
| US20030153756A1 (en) | 2003-08-14 |
| JO2242B1 (en) | 2004-10-07 |
| CN100402530C (zh) | 2008-07-16 |
| PL371180A1 (en) | 2005-06-13 |
| EP1467996A1 (en) | 2004-10-20 |
| DE60207759T2 (de) | 2006-08-03 |
| KR20040068981A (ko) | 2004-08-02 |
| KR100601769B1 (ko) | 2006-07-19 |
| CA2471265A1 (en) | 2003-07-10 |
| BR0215395A (pt) | 2004-12-07 |
| CN1610683A (zh) | 2005-04-27 |
| PE20030896A1 (es) | 2003-11-05 |
| CA2471265C (en) | 2010-02-09 |
| WO2003055883A1 (en) | 2003-07-10 |
| JP2005517677A (ja) | 2005-06-16 |
| AU2002367190B2 (en) | 2006-10-05 |
| TW200306313A (en) | 2003-11-16 |
| AU2002367190A1 (en) | 2003-07-15 |
| UY27606A1 (es) | 2003-06-30 |
| ES2252554T3 (es) | 2006-05-16 |
| JP4188839B2 (ja) | 2008-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE311388T1 (de) | Pyrimidotriazine als phosphataseinhibitoren | |
| IL160915A0 (en) | Indolizines inhibiting kinase proteins | |
| SE0101675D0 (sv) | Novel composition | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| NO20073801L (no) | Atineoplastiske kombinasjoner | |
| DE69528829D1 (de) | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption | |
| EA199900373A2 (ru) | Фармацевтические композиции | |
| ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
| MXPA05013553A (es) | Pirrolodihidroisoquinolinas como inhibidores de pde10. | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| PT1473036E (pt) | Solvato de hemitartarato de zolpidem | |
| DE602004027251D1 (de) | Herstellung von 1,3-diphenylprop-2-en-1-onderivaten | |
| PE20011085A1 (es) | Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos | |
| SE9901077D0 (sv) | Novel use | |
| TR200002932T2 (tr) | Azabisayklik 5HT1 Alıcı liganolları | |
| SE9801494D0 (sv) | Novel use | |
| NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
| ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
| GB0103045D0 (en) | Organic Compounds | |
| ATE389657T1 (de) | Diaminopyrrolochinazoline als protein-tyrosin- phosphatase-inhibitoren | |
| PL1633754T3 (pl) | Związki diaminopirolochinazolinowe jako inhibitory białkowych fosfataz tyrozynowych | |
| WO2004020466A8 (en) | Protein tyrosine phosphatase inhibitors | |
| PT1144348E (pt) | Inibidores de lta, hidrolase | |
| MXPA04004757A (es) | Uso de una ascomicina para el tratamiento de blefaritis. | |
| MXPA03005400A (es) | Metodo para preparacion de 11 (12)-pentadecen-15-olidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1467996 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |